everything you want to know (and don't) about arkansas politics

Bi-partisan Sponsorship
Healthcare

SB534

To Establish The Arkansas Kratom Consumer Protection Act; And To Remove Mitragynine And 7-hydroxymitragynine, Also Known As Kratom, From The Controlled Substances List In Arkansas.

Failed

Last Action (May 5, 2025): Died in House at Sine Die adjournment.

Sponsors

AI-Generated Summary

Senate Bill 534 establishes the Arkansas Kratom Consumer Protection Act to regulate the sale and distribution of kratom products in the state. The bill removes mitragynine and 7-hydroxymitragynine from the Arkansas controlled substances list, effectively legalizing kratom under a new regulatory framework. It mandates labeling requirements, sets an age restriction prohibiting the sale of kratom to individuals under 18, and forbids the sale of products adulterated with dangerous substances or synthetic alkaloids. Processors are required to register their products annually with the Arkansas Department of Agriculture, provide third-party certificates of analysis, and report adverse events. The bill outlines enforcement procedures, including administrative fines for violations, while providing a good-faith defense for retailers who rely on processor representations. The legislation is driven by the goal of implementing safety standards for a product that some view as a potential harm-reduction tool.

Potential Impact Analysis

Who Might Benefit?

The primary beneficiaries are consumers who use kratom for personal reasons, including those seeking potential therapeutic benefits or alternatives to traditional opioids. Additionally, the kratom industry, including manufacturers, processors, and retailers, benefits from the creation of a clear legal framework that allows for the legitimate sale and distribution of these products in Arkansas.

Who Might Suffer?

Entities that may be negatively impacted include health advocacy groups or law enforcement agencies concerned about the potential for abuse, addiction, or public health risks associated with the widespread availability of kratom. Additionally, businesses that are unable or unwilling to comply with the new registration, testing, and labeling requirements may face increased administrative costs or the loss of the ability to sell these products legally.

Vote Records

Third Reading

April 7, 2025
Yea: 24 Nay: 5 NV: 6 Absent: 0 Passed
View individual votes (35)
Legislator Party Chamber Vote
Jane English Republican Senate NV
Jonathan Dismang Republican Senate Yea
Greg Leding Democrat Senate Yea
Missy Irvin Republican Senate Yea
Bryan King Republican Senate Yea
Kim Hammer Republican Senate NV
Stephanie Flowers Democrat Senate Yea
Frederick Love Democrat Senate Yea
Terry Rice Republican Senate Yea
Reginald Murdock Democrat Senate Yea
Gary Stubblefield Republican Senate Nay
Jim Dotson Republican Senate Yea
John Payton Republican Senate NV
Alan Clark Republican Senate Yea
Ronald Caldwell Republican Senate NV
Bart Hester Republican Senate Yea
Jimmy Hickey Republican Senate NV
Dan Sullivan Republican Senate NV
David Wallace Republican Senate Yea
Blake Johnson Republican Senate Yea
Justin Boyd Republican Senate Yea
Clarke Tucker Democrat Senate Yea
Scott Flippo Republican Senate Yea
Clint Penzo Republican Senate Yea
Mark Johnson Republican Senate Nay
Ricky Hill Republican Senate Yea
Jamie Scott Democrat Senate Yea
Breanne Davis Republican Senate Yea
Ben Gilmore Republican Senate Nay
Joshua Bryant Republican Senate Yea
Matt McKee Republican Senate Yea
Jim Petty Republican Senate Yea
Steve Crowell Republican Senate Yea
Tyler Dees Republican Senate Nay
Matt Stone Republican Senate Nay
Read Full Bill on arkleg.state.ar.us